AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00531-07v1
52/3/1195    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graham, M.
Right arrow Articles by Grayson, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graham, M.
Right arrow Articles by Grayson, M. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2008, p. 1195-1197, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.00531-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

High Rates of Fecal Carriage of Nonenterococcal vanB in both Children and Adults{triangledown}

M. Graham,1 S. A. Ballard,1 E. A. Grabsch,2 P. D. R. Johnson,1,3 and M. L. Grayson1,3,4*

Infectious Diseases,1 Microbiology Departments, Austin Health, Heidelberg,2 Department of Medicine, University of Melbourne,3 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia4

Received 22 April 2007/ Returned for modification 2 July 2007/ Accepted 21 December 2007

We examined the rate of fecal carriage of vanB in the absence of cultivable vancomycin-resistant enterococci in three distinct populations (children, community adults, and hemodialysis patients). Nonenterococcal vanB carriage was similarly high in hemodialysis patients (45%) and community adults (63%; P = 0.066) and significantly more common among community adults than children (27%; P = 0.001).

* Corresponding author. Mailing address: Infectious Diseases Department, Austin Hospital, Austin Health, Studley Rd., Heidelberg, VIC, Australia 3084. Phone: (613) 9496-6676. Fax: (613) 9496-6677. E-mail: Lindsay.Grayson{at}austin.org.au

{triangledown} Published ahead of print on 7 January 2008.

Antimicrobial Agents and Chemotherapy, March 2008, p. 1195-1197, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.00531-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.